We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A recent independent clinical test of the assay in Europe with 1,928 participants found that 16.5 percent (318 people) tested positive for respiratory viruses, excluding COVID-19. Read More
NICE is recommending further UK-based research to confirm the positive results compiled so far for people with long-term catheters and to determine whether people with short-term catheters would benefit from using UroShield. Read More
Paige Breast Lymph Node has not yet been approved or cleared by the FDA for use in diagnostic procedures, although it is available for research purposes. Read More
The clearance covers the device’s use in an anterior approach that will be particularly useful for deformity correction, said Stéphane Bette, SpineGuard’s co-founder and deputy CEO. Read More